Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Gemma Frisius Fund

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 34
Average round size
info
The average size of a deal this fund participated in
$7M
Portfolio companies 25
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.26
Exits 4
Key employees Soon
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Manufacturing
Summary

The venture was found in Europe in Belgium. The leading representative office of defined VC is situated in the Leuven.

Opposing the other organizations, this Gemma Frisius Fund works on 9 percentage points less the average amount of lead investments. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2018. Speaking about the real fund results, this VC is 5 percentage points less often commits exit comparing to other organizations. Deals in the range of 5 - 10 millions dollars are the general things for fund.

We can highlight the next thriving fund investment areas, such as Information Technology, Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Belgium. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Aristo Music Technology, TROD Medical, Cartagenia.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Gemma Frisius Fund, startups are often financed by Limburgse Reconversie Maatschappij, Vesalius Biocapital Partners, Quest for Growth. The meaningful sponsors for the fund in investment in the same round are PMV, Limburgse Reconversie Maatschappij, University of Leuven. In the next rounds fund is usually obtained by Flanders Innovation and Entrepreneurship (VLAIO), SmartFin Capital, PMV.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Gemma Frisius Fund:
Typical Co-investors
Gemma Frisius Fund is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Gemma Frisius Fund:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Belgium
Funds with similar focus located in Belgium:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Augustine Therapeutics

Biopharma
Biotechnology
Pharmaceutical
$20M26 Jun 2024 Ghent, East Flanders, Belgium

Protealis

$25M23 Jan 2024 -

DName-iT

Genetics
Medical
Productivity Tools
$685K30 Jun 2023 Belfast, Northern Ireland, United Kingdom

Dualyx

Biotechnology
Health Care
Medical
$47M15 May 2023 Ghent, Oost-Vlaanderen, Belgium

Rewind Therapeutics

Biotechnology
Therapeutics
25 Jan 2023 -

AstriVax

Clinical Trials
Medical
$35M25 Aug 2022 Heverlee, Vlaams-Brabant, Belgium

Aphea.Bio

Agriculture
Biotechnology
Chemical
$21M14 Apr 2021 Ghent, East Flanders, Belgium

Aphea.Bio

Agriculture
Biotechnology
Chemical
$4M01 Apr 2021 Ghent, East Flanders, Belgium

Runeasi

Fitness
Health Care
Sports
Wearables
$413K01 Nov 2020 Leuven, Vlaams-Brabant, Belgium

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Gemma Frisius Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 34
Average round size 7M
Peak activity year 2019
Lead investments 3
Follow on index 0.26
Exits 4
Group Appearance index 0.97

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Augustine Therapeutics

Biopharma
Biotechnology
Pharmaceutical
$20M26 Jun 2024 Ghent, East Flanders, Belgium

Protealis

$25M23 Jan 2024 -

DName-iT

Genetics
Medical
Productivity Tools
$685K30 Jun 2023 Belfast, Northern Ireland, United Kingdom

Dualyx

Biotechnology
Health Care
Medical
$47M15 May 2023 Ghent, Oost-Vlaanderen, Belgium

Rewind Therapeutics

Biotechnology
Therapeutics
25 Jan 2023 -

AstriVax

Clinical Trials
Medical
$35M25 Aug 2022 Heverlee, Vlaams-Brabant, Belgium

Aphea.Bio

Agriculture
Biotechnology
Chemical
$21M14 Apr 2021 Ghent, East Flanders, Belgium

Aphea.Bio

Agriculture
Biotechnology
Chemical
$4M01 Apr 2021 Ghent, East Flanders, Belgium

Runeasi

Fitness
Health Care
Sports
Wearables
$413K01 Nov 2020 Leuven, Vlaams-Brabant, Belgium
Crunchbase icon

Content report

The following text will be sent to our editors: